Associations of erythrocyte omega-3 fatty acids with cognition, brain imaging and biomarkers in the Alzheimer’s disease neuroimaging initiative: cross-sectional and longitudinal retrospective analyses

Document Details

Document Type
Pub Defense Publication
Publication Date
Dec 01, 2022
Source ID
10.1093/ajcn/nqac236

Entities

People

  • Bruno Vellas
  • Christelle Cantet
  • Daniel Catheline
  • Julien Delrieu
  • Kelly Virecoulon Giudici
  • Laure Rouch
  • Michael Weiner
  • Philipe De Souto Barreto
  • Philippe Legrand
  • Sandrine Andrieu
  • Sophie Guyonnet

Organizations

  • Alzheimer's Disease Neuroimaging Initiative
  • Alzheimer's Drug Discovery Foundation
  • Bristol-Myers Squibb
  • Canadian Institutes of Health Research
  • Chiron Corporation
  • Eli Lilly and Company
  • Fondation de l'Avenir
  • Foundation for the National Institutes of Health
  • GE HealthCare
  • Hoffmann-La Roche
  • Johnson & Johnson Pharmaceutical Research and Development
  • Meso Scale Diagnostics (United States)
  • National Institute of Biomedical Imaging and Bioengineering
  • National Institute on Aging
  • National Institutes of Health
  • Northern California Institute for Research and Education
  • Takeda Pharmaceutical Company
  • United States Department of Defense
  • University of Southern California